39 results
8-K
EX-99.1
ETON
Eton Pharmaceuticals Inc
2 Feb 24
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
6:55am
patients*, as well as prescription fulfillment, insurance benefits investigation, educational support, and financial assistance for qualifying patients
8-K
EX-99.1
ETON
Eton Pharmaceuticals Inc
4 Oct 23
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
6:55am
. The program is designed to help patients access treatment, providing prescription fulfillment services, insurance benefits investigation, educational support
8-K
EX-99.1
ETON
Eton Pharmaceuticals Inc
10 May 23
Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution
6:50am
will provide prescription fulfillment, insurance benefits investigation, educational support, and will provide qualified patients financial assistance along
8-K
ETON
Eton Pharmaceuticals Inc
10 May 23
Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution
6:50am
will provide prescription fulfillment, insurance benefits investigation, educational support, and will provide qualified patients financial assistance
8-K
EX-99.1
2cea7l 95d
20 Dec 21
Other Events
8:30am
8-K
EX-1.1
5g33kj e87mc3jatpo
8 Apr 21
Other Events
8:05am
8-K
EX-99
faegl8iphq py
24 Nov 20
Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDIĀ® SPRINKLE (hydrocortisone) in the United States
4:38pm
8-K
EX-1.1
3ru tpzy60yu7
14 Oct 20
Eton Pharmaceuticals Announces Proposed Public Offering of Common Stock
8:53am
S-3
EX-5.1
8itsb7173r xum8vrltf
2 Dec 19
Shelf registration
5:04pm